S

Shamaparavin

Active Director Director DIN 09582385
DIN 09582385 First appointment Apr 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Shamaparavin

Data last updated:

Shamaparavin is a Director at Endcure Pharma Private Limited (since 2022). The company operates in Healthcare. Endcure Pharma Private Limited reported revenue of ₹12.5 Lakh (FY 2025).

DIN 09582385
Primary Designation Director
Industry Healthcare
First Appointment 22 Apr 2022
Oldest Company Age 4 yrs
Largest company Endcure Pharma Private Limited · ₹12.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Endcure Pharma Private Limited U85100MH2022PTC381177
Director22 Apr 20222022₹12.5 Lakh (FY 2025)Active

Board colleagues of Shamaparavin

NameDINCompanyDesignation
Hena Akhtar10827476Endcure Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Endcure Pharma Private Limited
Premium access

Shareholding and investment profile for Shamaparavin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shamaparavin

Shamaparavin currently holds 1 directorship: Endcure Pharma Private Limited (Director, since 22 Apr 2022, revenue ₹12.5 Lakh (FY 2025)).

Shamaparavin was first appointed on 22 Apr 2022 as Director at Endcure Pharma Private Limited.

The current boards of Shamaparavin's companies include Hena Akhtar (Endcure Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available